Drugs and Diagnostics
Product Cards are accessible, easy-to-understand summaries of DRTB drugs and diagnostics, covering both market-available products and those in the pipeline, with a focus on key hurdles to uptake and scale-up. Each card synthesizes critical information: mechanism of action and clinical efficacy data, WHO prequalification status, current pricing, procurement mechanisms, and supply chain considerations, access barriers, and recommended advocacy asks. Product Cards are practical tools for civil society engaging with national, regional, and global health actors to accelerate the uptake of new and underutilized TB health technologies.